Document is current
Any future updates will be listed below
-
Authors
Thorlund, Jonas B. https://orcid.org/0000-0001-7789-8224
Skarpsno, Eivind S. https://orcid.org/0000-0002-4135-0408
Vestergaard, Jonas J. https://orcid.org/0009-0004-7132-1722
Skou, Søren T. https://orcid.org/0000-0003-4336-7059
Grønne, Dorte T. https://orcid.org/0000-0002-8235-1175
Roos, Ewa M. https://orcid.org/0000-0001-5425-2199
Vaegter, Henrik B. https://orcid.org/0000-0002-7707-9947
-
Funding
Funding for this research was provided by:
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 10 January 2025
Accepted: 11 April 2025
First Online: 25 April 2025
Declarations
:
: Part of the data was presented as an abstract at the World Congress on Osteoarthritis (OARSI) 2024: Osteoarthritis Cartilage 2024;32(Suppl 1):S194. AI was used for checking of spelling, grammar and language editing.
: No part of this paper has been copied or published elsewhere in whole or in part.
: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit .
: STS and EMR are the founders of GLA: D®. GLA: D® is a non-for-profit initiative hosted at University of Southern Denmark aimed at implementing clinical guidelines for osteoarthritis in clinical practice. Furthermore, STS has received personal fees from Munksgaard, TrustMe-Ed, and Nestlé Health Science outside the submitted work. HBV has received a speaker’s fee from AGB Pharma outside the submitted work.
